Wall Street is positive on NextCure Inc (NXTC). On average, analysts give the stock a Buy rating. The average price target is $5, which means analysts expect the stock to gain by 284.62% over the next twelve months.
That average ranking earns the stock an Analyst Rating of 30, which is better than 30% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating NXTC a Buy today. Find out what this means to you and get the rest of the rankings on NXTC!
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With NextCure Inc Stock Today?
NextCure Inc (NXTC) stock is unmoved 0% while the S&P 500 is higher by 0.03% as of 11:05 AM on Thursday, Oct 12. NXTC is flat $0.00 from the previous closing price of $1.30 on volume of 16,161 shares. Over the past year the S&P 500 has risen 22.40% while NXTC is lower by -53.74%. NXTC lost -$2.53 per share the over the last 12 months.
Click Here to get the full Stock Report for NextCure Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
